Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
Abstract Genomic sequencing of hepatocellular carcinoma (HCC) uncovers a paucity of actionable mutations, underscoring the necessity to exploit epigenetic vulnerabilities for therapeutics. In HCC, EZH2-mediated H3K27me3 represents a major oncogenic chromatin modification, but how it modulates the th...
Saved in:
Published in | Nucleic acids research Vol. 46; no. 17; pp. 8832 - 8847 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
28.09.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!